Research Strategic Plan 2012-2015

Significant progress has been made over the past few years to improve our understanding of prostate cancer. Many of these findings have resulted in improved methods to detect and treat the disease. However, there is still much to understand about the topic, including:
  • What is the exact cause of prostate cancer?
  • How can it be detected earlier?
  • How can prostate cancer be treated more effectively and with fewer side effects?
  • How can men and their families be supported throughout their prostate cancer journey?
Continued research efforts are important in all of these areas to provide the necessary evidence to improve prevention, detection, treatment and survivorship. With this in mind, Prostate Cancer Canada developed a Research Strategic Plan identifying key strategic priorities for research as well as the specific research programs that will be supported.
 
Over the next three years, the goals of the strategy are to:
 
  1. Outline strategic investments in prostate cancer research that will have the greatest impact on the disease.
  2. Develop innovative programs that build and sustain an outstanding Canadian prostate cancer research community.
  3. Train and help retain the next generation of prostate cancer research leaders.

The strategy is shaped by the following principles. The strategy will:
  1.  Build on and leverage existing prostate cancer researc h projects and infrastructure in Canada.
  2.  Establish rigorous peer-review processes to ensure only the highest-quality research is supported.
  3.  Provide opportunities for provincial, national and international partnerships by being informed by the CCRA Pan-Canadian Cancer Research Strategy. 
  4. Develop robust evaluation indicators to assess performance of programs and the overall strategy.
  5. Respond to opportunities that arise in prostate cancer research.
  6. Achieve results that strengthen the ability to raise additional funds for research.
     
To read the entire Research Strategic Plan 2012-2015, please click here.

The companion documents
 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive